An integrated approach for the rational design of nanovectors for biomedical imaging and therapy.
The use of nanoparticles for the early detection, cure, and imaging of diseases has been proved already to have a colossal potential in different biomedical fields, such as oncology and cardiology. A broad spectrum of nanoparticles are currently under development, exhibiting differences in (i) size, ranging from few tens of nanometers to few microns; (ii) shape, from the classical spherical beads to discoidal, hemispherical, cylindrical, and conical; (iii) surface functionalization, with a wide range of electrostatic charges and biomolecule conjugations. Clearly, the library of nanoparticles generated by combining all possible sizes, shapes, and surface physicochemical properties is enormous. With such a complex scenario, an integrated approach is here proposed and described for the rational design of nanoparticle systems (nanovectors) for the intravascular delivery of therapeutic and imaging contrast agents. The proposed integrated approach combines multiscale/multiphysics mathematical models with in vitro assays and in vivo intravital microscopy (IVM) experiments and aims at identifying the optimal combination of size, shape, and surface properties that maximize the nanovectors localization within the diseased microvasculature.
Godin
Biana
B
Department of Nanomedicine and Biomedical Engineering, The University of Texas Health Science Center, Houston, Texas, USA.
Driessen
Wouter H P
WH
Proneth
Bettina
B
Lee
Sei-Young
SY
Srinivasan
Srimeenakshi
S
Rumbaut
Rolando
R
Arap
Wadih
W
Pasqualini
Renata
R
Ferrari
Mauro
M
Decuzzi
Paolo
P
D003952:Diagnostic Imaging / Q000379:methods*; D008954:Models, Biological; D053758:Nanoparticles / Q000737:chemistry / Q000627:therapeutic use*; D010316:Particle Size; D013499:Surface Properties
Clin Cancer Res. 1999 Jan;5(1):83-94
9918206
J Biomech. 2008 Jul 19;41(10):2312-8
18571181
Pharm Res. 2009 Jan;26(1):235-43
18712584
J Control Release. 2000 Mar 1;65(1-2):271-84
10699287
FASEB J. 2009 Oct;23(10):3361-7
19535683
Am J Physiol Heart Circ Physiol. 2007 Sep;293(3):H1526-35
17526647
Microcirculation. 2004 Apr-May;11(3):239-47
15280078
Cancer Res. 1998 Aug 1;58(15):3320-30
9699662
Adv Drug Deliv Rev. 2000 Sep 30;43(2-3):101-64
10967224
Nat Nanotechnol. 2007 Dec;2(12):751-60
18654426
Biomaterials. 2008 Jan;29(3):377-84
17936897
Clin Pharmacokinet. 2006;45(10):965-88
16984211
Annu Rev Biomed Eng. 1999;1:241-63
11701489
Am J Physiol. 1998 Jun;274(6):H2018-24
9841528
Microvasc Res. 1984 Mar;27(2):204-22
6708830
Curr Drug Deliv. 2005 Oct;2(4):369-81
16305440
Clin Cancer Res. 2008 Feb 1;14(3):731-41
18245533
Targeted Diagn Ther. 1990;3:3-22
2131014
J Biomech. 2009 Aug 25;42(12):1885-90
19523635
Trends Cardiovasc Med. 2006 Apr;16(3):80-8
16546688
Am J Physiol Heart Circ Physiol. 2000 Oct;279(4):H2017-23
11009493
Nat Rev Cancer. 2002 Oct;2(10):750-63
12360278
Nat Nanotechnol. 2008 Mar;3(3):151-7
18654487
Clin Cancer Res. 2002 Apr;8(4):1172-81
11948130
Crit Rev Ther Drug Carrier Syst. 1992;9(2):135-87
1386002
J Cell Biol. 1995 Sep;130(5):1189-96
7657703
Biorheology. 2004;41(6):693-714
15851845
Proc Natl Acad Sci U S A. 2006 Apr 18;103(16):6315-20
16606824
Trends Biotechnol. 2008 Aug;26(8):442-9
18571753
J Nanobiotechnology. 2008 Aug 15;6:9
18702833
Nature. 2005 Jul 28;436(7050):568-72
16049491
Am J Pathol. 2007 Sep;171(3):838-45
17675580
Biochim Biophys Acta. 1991 Feb 25;1062(2):142-8
2004104
AAPS J. 2007 May 11;9(2):E128-47
17614355
Microcirculation. 2002 Jul;9(3):177-87
12080415
Nat Nanotechnol. 2008 May;3(5):242-4
18654511
Nat Nanotechnol. 2008 Mar;3(3):131-2
18654480
Int J Pharm. 2010 Jan 4;383(1-2):178-85
19732814
J Clin Oncol. 2005 Nov 1;23(31):7794-803
16172456
Trends Cardiovasc Med. 2008 May;18(4):126-32
18555185
Clin Pharmacol Ther. 2008 May;83(5):761-9
17957183
Nat Nanotechnol. 2008 Mar;3(3):145-50
18654486
Int Immunopharmacol. 2003 Mar;3(3):319-28
12639809
Microsc Res Tech. 2007 Sep;70(9):776-81
17576122
Jpn J Cancer Res. 1994 Apr;85(4):331-4
7515384
Biochem Soc Trans. 1995 Nov;23(4):1073-9
8654684
Science. 1983 Feb 25;219(4587):983-5
6823562
Prog Lipid Res. 2003 Sep;42(5):439-62
12814645
PLoS One. 2008 May 21;3(5):e2242
18493583
Bioorg Med Chem Lett. 2008 Mar 15;18(6):1835-9
18294846
Adv Drug Deliv Rev. 2004 Sep 22;56(11):1649-59
15350294
Biophys J. 1998 Jun;74(6):3264-72
9635780
Microcirculation. 2005 Apr-May;12(3):259-74
15814435
Expert Opin Biol Ther. 2008 Aug;8(8):1063-70
18613759
Circ Res. 1996 Sep;79(3):581-9
8781491
Adv Drug Deliv Rev. 2006 Dec 30;58(15):1622-54
17123658
Anticancer Drugs. 2005 Aug;16(7):691-707
16027517
Curr Opin Chem Biol. 2005 Aug;9(4):343-6
15967706
Ann Biomed Eng. 2004 Jun;32(6):793-802
15255210
Cancer Res. 2006 Oct 15;66(20):10073-82
17047071
Int J Nanomedicine. 2007;2(4):541-50
18203422
J Control Release. 2006 Sep 12;114(3):277-87
16904220
J Control Release. 2001 Jul 6;74(1-3):193-202
11489495
Biomaterials. 2007 Jun;28(18):2915-22
17363051
Cell. 2006 Apr 21;125(2):385-98
16630824
Cancer Res. 2000 Feb 1;60(3):722-7
10676659
Biochem J. 2004 Jan 1;377(Pt 1):159-69
14505488
Biomaterials. 2006 Oct;27(30):5307-14
16797691
J Liposome Res. 2002 Feb-May;12(1-2):5-12
12604033
Invest Ophthalmol Vis Sci. 2006 Nov;47(11):4794-802
17065490
Science. 1989 Dec 8;246(4935):1306-9
2479986
Langmuir. 2007 Mar 27;23(7):4019-25
17319706
Proc Natl Acad Sci U S A. 2006 Mar 28;103(13):4930-4
16549762
Ann Biomed Eng. 2005 Feb;33(2):179-90
15771271
Cancer Res. 1992 Oct 1;52(19):5144-53
1327501
Eur J Pharm Sci. 2005 May;25(1):81-9
15854804
Annu Rev Med. 2008;59:251-65
17937588
Pharmacol Rev. 1999 Dec;51(4):691-743
10581328
Nat Rev Cancer. 2005 Jun;5(6):436-46
15928674
Drug Resist Updat. 2005 Dec;8(6):381-402
16309948
Int J Pharm. 2004 Nov 5;285(1-2):23-34
15488676
Nature. 1998 Apr 30;392(6679 Suppl):5-10
9579855
Br J Cancer. 1996 Dec;74(11):1749-56
8956788
Exp Cell Res. 1998 Jul 10;242(1):265-73
9665824
Ann N Y Acad Sci. 2006 Oct;1082:116-9
17145932
Nat Rev Cancer. 2005 Mar;5(3):161-71
15738981
Cancer Res. 1988 Dec 15;48(24 Pt 1):7022-32
3191477
Angew Chem Int Ed Engl. 2009;48(5):872-97
19142939
Nat Biotechnol. 1997 Jun;15(6):542-6
9181576
Expert Opin Drug Deliv. 2006 May;3(3):311-24
16640493
Biomacromolecules. 2005 Mar-Apr;6(2):914-26
15762660
Bioconjug Chem. 2008 Jul;19(7):1327-38
18547095
Br J Cancer. 2003 Oct 20;89(8):1545-51
14562030
Nat Rev Drug Discov. 2003 May;2(5):347-60
12750738
Biophys J. 2003 Jul;85(1):637-45
12829517
Annu Rev Biomed Eng. 2007;9:257-88
17439359
Nat Rev Drug Discov. 2003 Mar;2(3):214-21
12612647
Cancer Metastasis Rev. 1987;6(4):559-93
3327633
Expert Opin Drug Deliv. 2007 Jul;4(4):359-69
17683250
Proc Natl Acad Sci U S A. 2006 Jan 31;103(5):1215-20
16434473
J Cell Sci. 2006 May 1;119(Pt 9):1903-13
16636075
Nat Rev Cancer. 2006 Sep;6(9):688-701
16900224
Cancer Res. 2001 Jun 15;61(12):4750-5
11406547
Int J Nanomedicine. 2007;2(4):689-96
18203435
Radiology. 2002 Sep;224(3):823-9
12202721
Science. 2002 Jun 28;296(5577):2404-7
12089446
Mol Ther. 2003 Jan;7(1):11-8
12573613
Cancer Cell. 2004 Feb;5(2):151-62
14998491
Mol Ther. 2008 Aug;16(8):1450-8
18560419
Biorheology. 2001;38(5-6):415-28
12016324
Proc Natl Acad Sci U S A. 2003 Nov 11;100(23):13549-54
14597719
Microvasc Res. 2002 Jul;64(1):21-31
12074627
Nat Rev Drug Discov. 2005 Feb;4(2):145-60
15688077